Literature DB >> 1850380

Cutaneous cryptococcosis in athymic and beige-athymic mice.

C A Salkowski1, E Balish.   

Abstract

The dermotropism of Cryptococcus neoformans SLHA in congenitally athymic (nu/nu) and doubly immunodeficient beige-athymic (bg/bg-nu/nu) mice is described. Both bg/bg-nu/nu and nu/nu mice developed cutaneous cryptococcosis within 7 to 12 days following intravenous challenge with 10(4) encapsulated yeast cells. Macroscopically, cutaneous lesions appeared as small subcutaneous nodules without ulceration. Cryptococcal skin lesions were observed primarily on the flank of nu/nu mice, whereas skin lesions in bg/bg-nu/nu mice were distributed over the trunk, abdomen, and face. While bg/bg-nu/nu mice had four times as many macroscopic skin lesions as nu/nu mice on day 14 after intravenous challenge, the skin lesions in nu/nu mice were larger. Histopathology revealed large foci of encapsulated yeasts extending from the basement membrane of the epidermis through the dermis to the underlying musculature. Yeasts in these lesions evoked a minimal inflammatory response that consisted primarily of macrophages. Interestingly, yeast cells appeared to be degrading collagen bundles located in the dermis. The dermotropic strain used in this study produced gelatinase and other proteases in vitro. These results indicate that C. neoformans can be dermotropic in a T-cell-deficient host and that proteases may be a virulence factor(s).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850380      PMCID: PMC257916          DOI: 10.1128/iai.59.5.1785-1789.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Metalloproteinases and their inhibitors in matrix remodeling.

Authors:  L M Matrisian
Journal:  Trends Genet       Date:  1990-04       Impact factor: 11.639

2.  Experimental cryptococcosis of the skin.

Authors:  M M Song
Journal:  Sabouraudia       Date:  1974-07

3.  Proteolytic activity of Cryptococcus neoformans against human plasma proteins.

Authors:  H E Müller; K K Sethi
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

4.  Cutaneous cryptococcosis. A sentinel of disseminated disease.

Authors:  G A Sarosi; P M Silberfarb; F E Tosh
Journal:  Arch Dermatol       Date:  1971-07

5.  Cutaneous manifestations of disseminated cryptococcosis.

Authors:  C W Schupbach; C E Wheeler; R A Briggaman; N A Warner; E P Kanof
Journal:  Arch Dermatol       Date:  1976-12

6.  Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

Authors:  L K Cauley; J W Murphy
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Histopathological studies on experimental cryptococcosis in nude mice.

Authors:  K Nishimura; M Miyaji
Journal:  Mycopathologia       Date:  1979-09-28       Impact factor: 2.574

8.  Host defense in cryptococcosis. II. Cryptococcosis in the nude mouse.

Authors:  J R Graybill; D J Drutz
Journal:  Cell Immunol       Date:  1978-10       Impact factor: 4.868

9.  Cryptococcus neoformans. I. Nonencapsulated mutants.

Authors:  G S Bulmer; M D Sans; C M Gunn
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

10.  Cutaneous cryptococcosis.

Authors:  A C Chu; R J Hay; D M MacDonald
Journal:  Br J Dermatol       Date:  1980-07       Impact factor: 9.302

View more
  5 in total

1.  Extracellular proteinase activity of Cryptococcus neoformans.

Authors:  L C Chen; E S Blank; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

Review 2.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.

Authors:  Loïc Guillot; Scott F Carroll; Robert Homer; Salman T Qureshi
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

Review 4.  What makes Cryptococcus neoformans a pathogen?

Authors:  K L Buchanan; J W Murphy
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

5.  Risk factors for invasive Cryptococcus neoformans diseases: a case-control study.

Authors:  Ying-Ying Lin; Stephanie Shiau; Chi-Tai Fang
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.